INS and obesity due to melanocortin 4 receptor deficiency: Conversely, two other studies report no changes in (tissue-specific) insulin sensitivity after either seven-day or 14-d oral vancomycin use (different doses) compared to control in males with obesity and insulin resistance and adults with obesity and impaired glucose tolerance, respectively.15